Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2007
11/01/2007US20070255058 Heterocyclic Compounds and Optical Recording Materials
11/01/2007US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254894 Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation
11/01/2007US20070254884 Compositions and Methods for Inducing Cell Dedifferentiation
11/01/2007US20070254882 Sulfamide Derivatives and Pharmaceutical Composition for Upregulation of Lipid Metabolism Comprising Same
11/01/2007US20070254881 Pyrazole Derivative
11/01/2007US20070254880 Heteroaryl Piperidine Glycine Transporter Inhibitors
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254849 Ryanodine receptor inhibitors and methods relating thereto
11/01/2007US20070254363 Substituted biaryl compounds for inflammation and immune-related uses
11/01/2007CA2650124A1 Oxadiazolidinedione compound
11/01/2007CA2650009A1 Il-8 receptor antagonists
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1848715A1 Compounds having tie2 (tek) inhibitory activity
10/31/2007EP1848713A2 Amide derivatives, their manufacture and use as pharmaceutical agents
10/31/2007EP1848711A1 Fungicidal pyrazine derivatives
10/31/2007EP1848710A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity
10/31/2007EP1848709A1 Novel salt form of a dopamine agonist
10/31/2007EP1848705A2 Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1286998B2 Oxazolidinone derivatives with antibiotic activity
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1202978B1 Isoxazolyl- and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065375A Compounds, compositions containing them, preparations thereof and uses thereof
10/31/2007CN101065367A Aryl-ureido benzoxazinone compounds
10/31/2007CN101065364A Novel pyrimidine derivatives and their use as PPAR-alpha modulators
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/30/2007US7288651 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288563 modulators of monocyte chemotactic proteins MCP-1 receptor; inflammatory diseases such as asthma and allergies, autoimmune diseases such as rheumatoid arthritis and atherosclerosis
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288540 Phenylalkynes
10/30/2007US7288538 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2171974C Substituted isoxazolines, process for their preparation, compositions containing them, and their use as safeners
10/25/2007WO2007120824A2 Processes for the synthesis of azetidinone
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007120600A2 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/25/2007WO2007120595A2 Amines for the treatment of hcv
10/25/2007WO2007120574A2 Diaryl substituted alkanes
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119833A1 Nitrogen-containing heterocyclic compound
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007WO2007118900A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118323A1 Isoxazole derivatives as calcium channel blockers
10/25/2007WO2007118314A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007WO2007106467A3 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt
10/25/2007WO2007085954A3 Aminophthalazine derivative compounds
10/25/2007WO2006135604A3 Inhibitors of checkpoint kinases
10/25/2007WO2006033844A9 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
10/25/2007US20070249842 Catalytic hydrogenation using ruthenium, rhodium complex catalyst; (Z)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-yl}-acrylic acid methyl ester
10/25/2007US20070249840 Process for the preparation of bis-benzazolyl compounds
10/25/2007US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249665 1-aryl-4-substituted isoquinolines
10/25/2007US20070249625 Il-8 Receptor Antagonists
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249607 Nk-1 and serotonin transporter inhibitors
10/25/2007US20070249606 2,4-dichloro-N-{[1- (isopropylsulfonyl)-4- (morpholine-4- ylcarbonyl)piperidin-4- yl]methyl}benzamide; selective GlyT1 uptake inhibitors; nervous system, psychological disorders; cognition activators; dementia; schizophrenia; Parkinson's/Alzheimer diseases;bipolar disorders; neuroleptic agents
10/25/2007US20070249603 3-Arylsulfonyl-Quinolines as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
10/25/2007US20070249602 Abnormal Cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249595 Novel Enantiomeric Pure Beta Agonists, Manufacturing and Use as a Medicament Thereof
10/25/2007US20070249580 Novel Cyclic Amino Benzoic Acid Derivative
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007CA2649288A1 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2648892A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2648642A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/25/2007CA2648555A1 Diaryl substituted alkanes
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007CA2643924A1 Isoxazole derivatives as calcium channel blockers
10/25/2007CA2643822A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 647